Home/Filings/4/0001140361-18-006264
4//SEC Filing

First Eagle Value in Biotechnology Master Fund, Ltd. 4

Accession 0001140361-18-006264

CIK 0001001902other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 3:24 PM ET

Size

14.3 KB

Accession

0001140361-18-006264

Insider Transaction Report

Form 4
Period: 2018-02-07
Transactions
  • Purchase

    Common Stock

    2018-02-08$6.32/sh+17,500$110,5864,337,814 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2018-02-07$6.35/sh+3,800$24,1224,320,314 total(indirect: See Footnote)
Transactions
  • Purchase

    Common Stock

    2018-02-07$6.35/sh+3,800$24,1224,320,314 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2018-02-08$6.32/sh+17,500$110,5864,337,814 total(indirect: See Footnote)
Transactions
  • Purchase

    Common Stock

    2018-02-08$6.32/sh+17,500$110,5864,337,814 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2018-02-07$6.35/sh+3,800$24,1224,320,314 total(indirect: See Footnote)
Transactions
  • Purchase

    Common Stock

    2018-02-07$6.35/sh+3,800$24,1224,320,314 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2018-02-08$6.32/sh+17,500$110,5864,337,814 total(indirect: See Footnote)
Footnotes (4)
  • [F1]This Form 4 is filed by 21 April Ltd. ("April Ltd."), First Eagle Investment Management, LLC ("FEIM"), First Eagle Value in Biotechnology Master Fund, Ltd. ("FEVIBM") and First Eagle Holdings, Inc. ("FEHI" and, collectively with April Ltd., FEIM and FEVIBM, the "Entities"). The Entities disclaim status as a "group" for purposes of this Form 4.
  • [F2]The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the "Funds"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the "Separately Managed Accounts". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
  • [F3]Represents 2,797,106, 299,662 and 1,223,546 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
  • [F4]Represents 2,812,541, 299,662 and 1,225,611 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.

Documents

1 file

Issuer

INTEVAC INC

CIK 0001001902

Entity typeother

Related Parties

1
  • filerCIK 0001457518

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 3:24 PM ET
Size
14.3 KB